Facebook
Twitter
LinkedIn
ForwardSymposium Guide
Boca Raton Regional Hospital Gastroenterology Symposium
Saturday, October 14, 2023 | 7:55 a.m. - 12 noon
Claim CME/CE Credit
Option 1: Text the six-letter code provided at the end of the symposium to (754) 203-8885. You will receive a message confirming your attendance.
Option 2: Scan the QR code shown below with your mobile phone, and enter the six-letter code provided at the symposium to receive your credit.
Evaluation
Once you have claimed your CME/CE credit, you will receive a link to your daily evaluation form via email and SMS.
Presentations
| 7:55 a.m. | Welcome and Introductions Kenneth Rosenthal, M.D. |
| 8:00 a.m. | Drug-Induced Liver Injury for the GI Practice Eric F. Martin, M.D. |
| 8:45 a.m. | Q&A |
| 9:00 a.m. | Gastroparesis: What Is It and Who Has It? Eamonn M. M. Quigley, M.D., FRCP, FACP, MACG, FRCPI, MWGO |
| 9:45 a.m. | Q&A |
| 10:00 a.m. | Nonerosive Reflux Disease: What Clinicians Need to Know in 2023 Karthik Ravi, M.D. |
| 10:45 a.m. | Q&A |
| 11:00 a.m. | What Every Gastroenterologist Should Know about Bariatric Surgery Nestor F. de la Cruz-Munoz, M.D., FACS |
| 11:45 a.m. | Q&A and Discussion |
| 12:00 noon | Closing Remarks and Adjourn Kenneth Rosenthal, M.D. |
Disclosures and Resolution of Conflict of Interest
- Nestor de la Cruz Munoz, M.D., faculty for this educational activity, has indicated that conducts research for USGI, Allurion, GI Dynamics Pivotal Clinical Trials. He has indicated that his presentation or discussion will not include off-label or unapproved product usage.
- Ravi Karthik, M.D., faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that his presentation or discussion will include off-label or unapproved product usage.
- Eric F. Martin, M.D., faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that his presentation or discussion will not include off-label or unapproved product usage.
- Eamonn M. M. Quigley M.D., FRCP, FACP, MACG, FRCPI, faculty for this educational activity, has indicated that he receives research funding from CinDome and Atmo. He is also on the advisory board for Atmo. He has indicated that his presentation or discussion will not include off-label or unapproved product usage.
All of the relevant financial relationships listed for these individuals have been mitigated.
Other individuals involved in planning, content review, approval, or moderating for this educational activity have no relevant financial relationships to disclose with ineligible companies*.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.